Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIROX2: S-1, Irinotecan, and Oxaliplatin in Untreated Metastatic Colorectal Cancer
NCT00506571Phase 2Unknown
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur in colorectal cancer (CRC), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
tegafur
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00506571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00506571.